Amplia Therapeutics (INNMF) Stock Price, Quote, News & History

Comments

Amplia Therapeutics Ltd (INNMF) Stock Price, Quote, News & History

INNMFOTCQB

Trade with Public

$0.1811

Last update: Mar 25, 12:02 PM

OverviewNews Short Interest

Key Statistics

Open

Volume / Avg.

0 / 24.48K

Day Range

- - -

52 Wk Range

0.03 - 0.27

Market Cap

$92.92M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.82

Recent Amplia Therapeutics Ltd News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-81.65K

Financing Cash Flow (TTM)

37.99M

Free Cash Flow (TTM)

-13.39M

Capital Expenditure (TTM)

-27.69K

Net Change in Cash (TTM)

24.55M

Valuation Metrics

Enterprise Value

$64.94M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

3.15

Earnings Yield % (TTM)

-7.72%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.06

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.86M

Debt to Equity

0.00

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 24.48K

Day Range

- - -

52 Wk Range

0.03 - 0.27

Market Cap

$92.92M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.82

About

Sector

Health Care

Industry

Biotechnology

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-actio...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Amplia Therapeutics (INNMF) stock?

You can purchase shares of Amplia Therapeutics (OTCQB:INNMF) through any online brokerage.

View our list of the best stock brokerages

Who are Amplia Therapeutics (INNMF) competitors?

There are no as such competitors for Amplia Therapeutics.

What is the forecast, or price target, for Amplia Therapeutics (INNMF) stock?

There is no analysis for Amplia Therapeutics to provide a consensus price target.

What is the current price for Amplia Therapeutics (INNMF)?

The stock price for Amplia Therapeutics (OTCQB: INNMF) is $0.1811 last updated March 25, 2026 at 12:02 PM EDT.

Does Amplia Therapeutics (INNMF) pay a dividend?

There are no upcoming dividends for Amplia Therapeutics.

When is Amplia Therapeutics (OTCQB:INNMF) reporting earnings?

Amplia Therapeutics does not have any upcoming earnings scheduled.

Is Amplia Therapeutics (INNMF) going to split?

There is no upcoming split for Amplia Therapeutics.

What sector and industry does Amplia Therapeutics (INNMF) operate in?

Amplia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.

Key Statistics

Open

Volume / Avg.

0 / 24.48K

Day Range

- - -

52 Wk Range

0.03 - 0.27

Market Cap

$92.92M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.82

Recent Amplia Therapeutics Ltd News

No news found